Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Microbiol ; 82(1): 55-60, 2001 Sep 03.
Article in English | MEDLINE | ID: mdl-11423195

ABSTRACT

An indirect enzyme-linked immunosorbent assay (ELISA) for the detection of Brucella abortus antibodies in bovine bulk milk samples was evaluated. About 31 individual milk samples from B. abortus infected cows were diluted into bulk milk from a brucellosis free herd. Individual milk samples obtained from 96 negative or positive herds to ELISA or Brucella ring test (BRT), were tested by ELISA. All positive cows were bled and serum samples were tested by the complement-fixation test (CFT) which was considered the definitive test. A herd was considered infected if at least, one cow was positive in the CFT. Four samples were negative in the BRT at the dilution 1:10 but positive in the ELISA. For samples positive in both tests, BRT titers ranged from 1:10 to 1:480 while ELISA titers ranged from 1:10 to 1:3200. Using bulk milk samples, the sensitivity of the ELISA (98.1%) was higher than the BRT (72.2%) but the specificity of BRT (90.5%) was not statistically different (P=1.0) from the ELISA (88.1%). The implications of the results for brucellosis control are discussed.


Subject(s)
Antibodies, Bacterial/analysis , Brucella abortus/isolation & purification , Enzyme-Linked Immunosorbent Assay/veterinary , Milk/microbiology , Animals , Cattle , Dairying , Enzyme-Linked Immunosorbent Assay/methods , Female , Food Microbiology
2.
Parasite ; 6(1): 67-9, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10229940

ABSTRACT

Combined inoculation of cattle with vaccine strains of Babesia bigemina and Babesia bovis induced lower antibody titers to B. bigemina than to B. bovis (previous study). Three groups of heifers were used to detect if the low antibody level was due to competition between Babesia species: individuals of G1 and G2 were inoculated with 10 million B. bigemina and B. bovis, respectively, and those of G3 with 10 million of each parasite. The prepatent periods, maximum parasitaemias and antibody titers (indirect immunofluorescent antibody test) were evaluated. The mean prepatent periods (days) for B. bigemina was of 5.6 (G1) and 5.2 (G3) and 7.0 (G2) and 6.7 (G3) for B. bovis (P > 0.05, "t" test). No differences were found in the parasitaemias. The only difference was found in the antibody titers to B. bovis, that were lower (P < 0.05 "t" test) from week 7 onwards when B. bovis was used in combination. The biological significance of this difference is unclear.


Subject(s)
Antibodies, Protozoan/biosynthesis , Babesia bovis/immunology , Babesia/immunology , Babesiosis/prevention & control , Cattle Diseases/prevention & control , Cattle/immunology , Protozoan Vaccines/immunology , Animals , Babesiosis/immunology , Babesiosis/parasitology , Cattle Diseases/immunology , Cattle Diseases/parasitology , Female , Fluorescent Antibody Technique, Indirect , Parasitemia/parasitology , Parasitemia/veterinary , Species Specificity , Vaccines, Attenuated/immunology , Vaccines, Combined/immunology
3.
Prev Vet Med ; 36(3): 211-7, 1998 Sep 01.
Article in English | MEDLINE | ID: mdl-9785376

ABSTRACT

An indirect enzyme-linked immunosorbent assay (ELISA) for Brucella abortus antibodies detection in bovine milk and serum samples was validated. The assay use B. abortus smooth lipopolysaccharide as antigen, immobilized on a polystyrene matrix; milk diluted 1:2 or serum diluted 1:50, in a buffer containing divalent cation chelating agents EDTA and EGTA (ethyleneglycol-bis-aminoether-N,N,N',N'-tetraacetic acid) to reduce non-specific reactions; and a mouse monoclonal antibody specific for an epitope of bovine IgG1, conjugated with horseradish peroxidase. A total of 2646 sera and 2119 milk samples from cows older than 24 months were obtained from 12 brucellosis-free herds for at least the previous 5 years. Milk samples were obtained in parallel with serum samples. The remaining 527 serum samples were from dry cows. All cattle were vaccinated with B. abortus strain 19 between 3-10 months of age. Five hundred and fifty-two milk samples and 562 serum samples were obtained from 6 infected herds with abortions where B. abortus was isolated at least once no more than 6 months before sampling. The complement-fixation test (CFT) on serum samples was considered the gold standard. Serum samples were also tested with the official screening test: the buffered plate antigen (BPA) test. The cut-off point was determined using receiver-operating characteristic (ROC) analysis. For milk samples, it was fixed at 36 percent positivity (PP) giving a sensitivity of 99.6% with a 95% confidence interval (CI) of 98.6-99.9%. The specificity was 99.1% (CI 98.9-99.4%). For serum samples, the cut-off was fixed at 53 PP giving a sensitivity of 99.6% (CI 98.6-99.9%) and a specificity 98.6% (CI 98-99%). The BPA test showed a relative sensitivity of 99.6% (CI 98.6-99.9%) and a relative specificity of 98.6% (CI 98.1-99%). Our results indicate that the indirect ELISA is a highly sensitive and specific test and can be adapted to process a large number of samples.


Subject(s)
Brucella abortus/isolation & purification , Brucellosis, Bovine/diagnosis , Dairying , Enzyme-Linked Immunosorbent Assay/veterinary , Milk/chemistry , Animals , Argentina , Cattle , Complement Fixation Tests/veterinary , Data Interpretation, Statistical , Enzyme-Linked Immunosorbent Assay/methods , Female , Immunoglobulin G/analysis , Immunoglobulin G/blood , Serologic Tests/methods
4.
Vet Parasitol ; 70(1-3): 33-9, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9195707

ABSTRACT

The efficacy of vaccination of Argentinean cattle against babesiosis and anaplasmosis using live immunogens was tested to detect specific antibodies in samples obtained about 60 days after vaccination. Under these conditions a higher than expected proportion of cattle failed to show antibodies against Babesia bigemina. Therefore, a study was designed to evaluate if this failure was due to insensitivity of the routine test to detect antibodies to B. bigemina or to lack of infectivity of the live vaccine. Four groups (G) of cattle were each inoculated subcutaneously with 10 million Babesia bovis (vaccinal strain R1A), 10 million B. bigemina (vaccinal strain S1A) and 10 million Anaplasma centrale (strain M1). G1 and G2 consisted of ten Angus bulls 20-24 months old and ten Angus bulls 15-18 months old, respectively; G3 and G4 consisted of ten and 16 Holstein 1-month-old male calves, respectively. Blood samples were obtained on days 0, 10, 20, 30, 40, 50 and 60 after vaccination and the sera were analysed with an indirect immunofluorescent (IFA) test to detect antibodies to B. bovis (baseline dilution for a positive result 1:60) and B. bigemina (baseline dilution 1:120). Positive IFA titres were considered as evidence of the infectivity of the Babesia vaccinal strains contained in the vaccine. All Angus bulls were found positive to antibodies against both Babesia species, by day 20 (B. bovis) and day 30 (B. bigemina), whereas 10-25% of Holstein calves were negative throughout. The partial lack of vaccine infectivity in the calves was considered to be a consequence of innate resistance of young calves to Babesia. Antibody titres to B. bovis and B. bigemina declined by day 60 after vaccination. However, all cattle that were positive to B. bovis antibodies on day 50 were still positive to the IFA test 10 days later while 10%, 30% and 12% of cattle of G1, G2 and G3 that were positive to B. bigemina antibodies on day 50 after vaccination were found negative to the IFA test on day 60. In future, samples taken on days 40-50 will be used for detection of B. bigemina antibodies in vaccinated cattle, on day 60 for A. centrale and on either occasion for B. bovis. The reaction to the inoculation of B. bigemina S1A strain appears to lag behind the reaction to B. bovis R1A strain. It is not certain if this is a normal reaction to this B. bigemina strain or the result of interaction with the B. bovis strain.


Subject(s)
Antibodies, Protozoan/blood , Babesia/immunology , Cattle/immunology , Protozoan Vaccines/immunology , Anaplasma/immunology , Animals , Bacterial Vaccines/immunology , Fluorescent Antibody Technique, Indirect/veterinary , Male , Vaccination/veterinary , Vaccines, Attenuated/immunology , Vaccines, Combined/immunology
5.
Prev Vet Med ; 30(2): 151-4, 1997 May.
Article in English | MEDLINE | ID: mdl-9234418

ABSTRACT

The prevalence of Babesia bovis antibodies was estimated by using an ELISA (98% sensitivity and 95% specificity). Sera were obtained from 165 calves (mean age and standard deviation: 9.7 +/- 2.7 months) from an area in Argentina known to be unfavourable for the development of the vector tick, Boophilus microplus. The area comprised about 300,000 ha used for cattle breeding. The cattle population of 55,000 included 12,000 cattle under 1 year of age. Cattle were maintained mainly on natural grasses in communal lands. The true prevalence of antibodies to Babesia bovis was 12.2% with a confidence interval of 7.6% to 18.2%, and an inoculation rate (h; daily probability of infection) of 0.0004. This confidence interval has its lower boundary in the area of endemic stability due to low h of Babesia bovis by the vector tick and the upper limit in the area of endemic instability. This type of analysis could help to decide the implementation of preventive measures (e.g. vaccination) rationally, even in remote areas (such as the one of the present study) with an extensive cattle industry.


Subject(s)
Antibodies, Protozoan/blood , Babesia bovis/immunology , Babesiosis/epidemiology , Babesiosis/prevention & control , Cattle Diseases/epidemiology , Cattle Diseases/prevention & control , Animals , Antibodies, Protozoan/immunology , Argentina/epidemiology , Breeding , Cattle , Cross-Sectional Studies , Disease Outbreaks/veterinary , Disease Vectors , Prevalence , Tick-Borne Diseases/epidemiology , Tick-Borne Diseases/immunology , Tick-Borne Diseases/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...